Ambrose John A., Tai Zaheed
Cardiac Care, Saint Vincents Hospital and Medical Center, 153 West 11th Street, Cronin 5-553, New York, NY 10011, USA.
Curr Treat Options Cardiovasc Med. 2002 Feb;4(1):25-39. doi: 10.1007/s11936-002-0024-2.
In the last 20 years there have been enormous advances in our understanding of the acute coronary syndromes and how to manage patients presenting with them. In the 1980s, we began to understand the importance of thrombus formation was in the pathophysiology of acute coronary syndromes. Randomized studies also showed that appropriate antithrombotic therapy reduced the subsequent occurrence of myocardial infarction and death. In the 1990s, other therapeutic modalities and particularly percutaneous coronary intervention have come to the forefront as effective therapy in these syndromes. The glycoprotein IIb/IIIa receptor antagonists along with coronary stent implantation have proved extremely beneficial in short- and long-term management. We also have learned the importance of risk-factor modification in preventing subsequent events. In the future, greater efforts will focus on primary prevention.
在过去20年里,我们对急性冠脉综合征以及如何治疗此类患者的认识有了巨大进展。在20世纪80年代,我们开始认识到血栓形成在急性冠脉综合征病理生理学中的重要性。随机研究还表明,适当的抗栓治疗可降低随后心肌梗死和死亡的发生率。在20世纪90年代,其他治疗方式,尤其是经皮冠状动脉介入治疗,已成为这些综合征的有效治疗方法。糖蛋白IIb/IIIa受体拮抗剂与冠状动脉支架植入术已被证明在短期和长期治疗中极为有益。我们也认识到改变危险因素在预防后续事件中的重要性。未来,将更加努力地聚焦于一级预防。